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Abstract Following in vitro translation of the 22 kDa 
peroxisomal membrane protein (Pmp22p), gel filtration analysis 
of the post-ribosomal supernatant revealed that Pmp22p forms 
two complexes. Complex I is of high molecular weight, results in 
a crosslinking product of 80 kDa, and by co-immunoprecipitation 
with anti-TCPl antibody was identified as TRiC. In complex II 
Pmp22p was crosslinked to a yet unknown polypeptide of 40 kDa 
(P40). This complex exhibited much higher efficiency to insert 
Pmp22p into the peroxisomal membrane compared to complex I. 
In a model we suggest that newly synthesized Pmp22p is first 
bound to TRiC before being transferred to P 4 0 which may 
function as a cytosolic Pmp22p receptor. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The peroxisomal membrane harbours a variety of activities 
like enzymes, substrate transporters, receptors, the machin-
eries for membrane protein insertion and matrix protein im-
port, the protein apparatus forming new peroxisomes and 
components that interconnect peroxisomes to the cytoskeleton 
[1^4]. Little is known on how all the proteins that participate 
in these various activities are transported to and inserted into 
the peroxisomal membrane. Work of Fujiki et al. [5] provided 
evidence that the major 22 k D a peroxisomal membrane pro-
tein (Pmp22p) is synthesized on free polyribosomes and thus 
is inserted into peroxisomes post-translationally [6]. This 
mechanism of protein insertion raises questions as to (i) 
how the extremely hydrophobic polypeptide chains are pro-
tected from aggregation during and after synthesis, (ii) how 
they are transported to and recognized by the target mem-
brane, and (iii) how they are inserted into the membrane. 
Dyer et al. [7] recently identified in Pmp47p of Candida bodinii 
a consensus motif mediating peroxisomal targeting. U p to 
now this motif has been found only in some PMPs of yeast 
and higher eukaryotes. Based on in vitro experiments we re-
cently reported that insertion of Pmp22p and PAF1 proceeds 
dependent on time and temperature, does not require the hy-
drolysis of ATP, and involves a proteinaceous component of 
the peroxisomal membrane. Two steps of the insertion process 
could be distinguished: binding to and insertion into the 
membrane [3,8]. 
In the present paper we address the question how a newly 
synthesized t ransmembrane polypeptide chain is kept soluble 
in the cytosol, a prerequisite for their post-translational trans-
port and insertion. Pmp22p served as the model protein, since 
previous observations have shown that 70-80% of Pmp22p 
synthesized by in vitro translation are soluble in a rabbit 
reticulocyte lysate. Detailed analysis of the lysate revealed 
that Pmp22p in the post-ribosomal supernatant exists in two 
polypeptide complexes, one of which could be identified as 
TCP1 ring complex (TRiC), the eukaryotic homolog of 
G r o E L [9-11]. In the second complex Pmp22p is bound to 
a single 40 k D a polypeptide (P40). 
2. Material and methods 
Peroxisomes and mitochondria were isolated from the liver of male 
Wistar rats treated with clofibrate for 5-10 days. The light mitochon-
drial fraction of the liver homogenate was further separated on a 
linear 14-45% (w/v) Nycodenz gradient as described previously [12]. 
Organelles were recovered by centrifugation and resuspended at a 
concentration of 10 mg/ml in buffer H (165 mM potassium acetate, 
3 mM magnesium acetate, 2.5 mM DTT, 10 mM HEPES-KOH pH 
7.4) containing 0.2 mM antipain and 0.02 mM leupeptin. For in vitro 
insertion [8] 20 ul of purified organelles were incubated for 1 h at 26°C 
with 200 ul of the appropriate fraction obtained by gel filtration of the 
translation mixture. 
In vitro transcription/translation was performed as described [8] 
using a commercial preparation of the rabbit reticulocyte lysate 
(Promega, Heidelberg, Germany) for translation. After removal of 
the ribosomes by high-speed centrifugation the supernatant was sep-
arated by gel filtration on a 10/30 Superdex G-200 column (Pharma-
cia, Freiburg, Germany) equilibrated with buffer H containing 80 mM 
potassium acetate. For in vitro transcription/translation in the E. coli 
T7/S30 extract (Promega, Heidelberg, Germany) Pmp22p-cDNA was 
subcloned into the pET-lla vector (Stratagene, Heidelberg, Ger-
many). 
Crosslinking of polypeptides to Pmp22p was carried out by using 
the hetero-bifunctional reagents, SPDP (A'-succinimidyl 3'-(2-pyridyl-
dithio) propionate) or Sulfo-MBS (meta-maleimidobenzoyl-JV-hydrox-
ysulfosuccinimide ester; Pierce, Germany) and added in concentra-
tions of 32 uM (SPDP) or 23 uM (Sulfo-MBS) to the polypeptide 
complexes. Incubations (500 ul final volume) were done for 90 min 
(SPDP) or 10 min (Sulfo-MBS) at 4°C. Reactions were terminated by 
the addition of excess Tris-HCl, pH 7.4, or Tris-HCl and DTT (Sulfo-
MBS) and the polypeptides were analysed by SDS-PAGE (6-20% 
gradient gel) and autoradiography. 
Microsequencing was performed following Western blotting (Fluo-
rotrans PALL, Portsmouth, UK), trypsinisation and separating the 
trypsin fragments by HPLC [13]. Two fragments were analysed ex-
actly matching the GroEL sequences DTTTIIDGVG and AA-
VEEGVVAG. 
The following antisera were used for immunoprecipitation: rabbit 
anti-Pmp22p [8], rat anti-TCPl (Biomol, Hamburg, Germany) and 
rabbit anti-GroEL, anti-DnaK, anti-DnaJ, kindly provided by Dr. 
H. Bujard (ZMBH, Heidelberg, Germany). Variable concentrations 
of the antibodies were pre-adsorbed onto protein A or protein G 
Sepharose and added to the polypeptides. 
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3. Results 
3.1. Pmp22p forms two post-translational complexes 
We synthesized Pmp22p by in vitro transcription/transla-
tion from its cDNA [14]. Following high-speed centrifugation 
of the translation mixture 70-80% of the synthesized Pmp22p 
were recovered from the supernatant in highly soluble form, 
whereas 20-30% were found in the pellet which mainly con-
sists of ribosomes. One likely reason for the solubility of 
newly synthesized Pmp22p is that the polypeptide during 
and/or after translation associates with cytosolic constituents 
of the reticulocyte lysate. Therefore we analysed the super-
natant by gel filtration. As shown in Fig. 1, Pmp22p was 
eluted from the gel filtration column within two peak fractions 
corresponding to apparent molecular weights of >400 kDa 
(complex I) and ~ 60 kDa (complex II), respectively. 
3.2. Insertion competence of the Pmp22p complexes 
In order to test the insertion competence of both Pmp22p 
complexes, we incubated equal amounts of Pmp22p present in 
complex I and II with isolated rat liver peroxisomes as de-
scribed previously [3,8]. The subtilisin-resistant portion of 
Pmp22p bound to peroxisomes was taken as correctly inserted 
polypeptide. According to this criterium both complexes were 
competent. However, complex II was about 3^1 times more 
efficient for Pmp22p insertion than complex I (Fig. 2A,B). 
Insertion was specific for peroxisomes and was not observed 
with isolated mitochondria. 
3.3. In complex I Pmp22p is associated with TRiC 
Unlike translation in the rabbit reticulocyte lysate, where 
80% of the synthesized Pmp22p was soluble, synthesis in an 
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Fig. 1. Gel filtration analysis of the reticulocyte lysate post-riboso-
mal supernatant after in vitro translation of Pmp22p. The post-ribo-
somal supernatant of the lysate (300 ul) is separated by Superdex 
G-200 chromatography. A: Aliquotes of the fractions obtained by 
gel filtration were analysed by SDS-PAGE and autoradiography. 
Pmp22p is eluted within two peak fractions corresponding to molec-
ular weights of >400 kDa (fractions 18-20) and 60 kDa (fractions 
25-27). B: Quantitative evaluation of the autoradiography shown in 
(A). The peak fractions of two molecular weight standards (ovalbu-
min, 43 kDa and aldolase, 158 kDa) are indicated by arrows. 
Subtilisin 
Triton/DOC 
Pmp22p 
Peroxisomes 
+ + 
+ 
-
Mitochondria 
+ + 
+ 
-
B 
Subtilisin 
Triton/DOC 
Pmp22p 
Peroxisomes 
+ + 
+ 
.. 
Mitochondria 
+ + 
+ 
— 
Fig. 2. Comparison of the efficiencies of complex I (A) and com-
plex II (B) for the insertion of Pmp22p into peroxisomal mem-
branes. Equal amounts of newly synthesized Pmp22p present in 
complex I and complex II (60000 dpm) were incubated with iso-
lated rat liver peroxisomes (200 ug) as outlined in Section 2. Mito-
chondria (200 ug) were used as controls demonstrating the peroxiso-
mal specificity of the insertion. 
E. coli in vitro translation system resulted in only about 10% 
soluble polypeptide. The vast majority of the synthesized 
Pmp22p was recovered from the pellet fraction. Gel chroma-
tographic analysis of the soluble portion demonstrated that 
Pmp22p was contained in a single high molecular weight com-
plex strikingly similar in its chromatographic behaviour to 
complex I of the reticulocyte lysate. A second peak corre-
sponding to complex II was not detected in the E. coli system. 
Silver staining of the polypeptides contained in the E. coli 
translation mixture and separated by gel filtration revealed 
co-elution of the newly synthesized Pmp22p with a 60 kDa 
polypeptide (Fig. 3A,B). By microsequencing we identified the 
polypeptide as the chaperonin GroEL, the E. coli Hsp60 ho-
molog. The direct association of Pmp22p with GroEL was 
demonstrated by co-immunoprecipitation of Pmp22p using a 
polyclonal anti-GroEL antiserum (Fig. 3C). Antibodies di-
rected against DnaK and DnaJ, the E. coli Hsp70 and 
Hsp40 homologs, were unable to co-immunoprecipitate 
Pmp22p. 
The eukaryotic, cytosolic equivalent of GroEL is the het-
ero-oligomeric TCP1 ring complex, TRiC. Therefore, we as-
sumed that the complex I of the reticulocyte lysate represents 
Pmp22p associated with TRiC. This assumption was substan-
tiated by co-immunoprecipitation of Pmp22p with a mono-
clonal anti-TCPl antibody (Fig. 4A,B). Using SPDP as a 
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Fig. 3. Characterization of the protein complex formed after in vitro 
translation of Pmp22p in the E. coli S30 extract. The S30 post-ribo-
somal supernatant was separated by gel filtration and fractions were 
analyzed for total protein by silver staining (A) and for newly syn-
thesized Pmp22p by autoradiography (B). C: Co-immunoprecipita-
tion of Pmp22p from the pooled fractions 17-19, obtained by gel 
filtration, using anti-GroEL antiserum (lane 3). Pmp22p immuno-
precipitated by a polyclonal anfi-Pmp22p antiserum is shown in 
lane 1 and by control serum in lane 2. Antisera directed against 
DnaK (lane 4) and DnaJ (lane 5) were unable to co-immunoprecipi-
tate Pmp22p. 
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Fig. 4. Characterization of complex I formed after in vitro transla-
tion of Pmp22p in the rabbit reticulocyte lysate. A: Co-immunopre-
cipitation using increasing concentrations of monoclonal rat anti-
TCP1 antibody is shown in lanes 3-6. Pmp22p immunoprecipitated 
by the polyclonal anti-Pmp22p antiserum and by control antiserum 
(rat IgG) is shown in lanes 1 and 2, respectively. B: Quantitative 
evaluation of the TCP1 co-imrnunoprecipitation. C: In the pooled 
fractions 18-20 (complex I), obtained by gel filtration of the lysate, 
Pmp22p is crosslinked to polypeptides of 80 and 130 kDa using the 
hetero-bifunctional reagent SPDP (1). In the control (2) the reagent 
was omitted. 
hetero-bifunctional chemical crosslinker, Pmp22p present in 
complex I formed two crosslink products of 80 and 130 
kDa (Fig. 4C) suggesting close association of Pmp22p with 
one or two TRiC subunits. 
3.4. In complex II Pmp22p is associated with a 40 kDa 
polypeptide 
To further characterize the composition of complex II, 
again chemical crosslinking was applied using the hetero-bi-
functional, water soluble reagent Sulfo-MBS which provides 
crosslinking by both a sulfhydryl- and an amino-reactive site. 
Since Pmp22p does not contain cysteine residues, the appear-
ance of Pmp22p crosslink products indicate formation of a 
hetero-oligomeric rather than homo-oligomeric complex. As 
shown in Fig. 5, Sulfo-MBS crosslinking of complex II re-
sulted in a single product of 60 kDa suggesting Pmp22p to 
be associated with a single 40 kDa polypeptide. 
4. Discussion 
In the present study we address the question of post-trans-
lational organisation of the extremely hydrophobic peroxiso-
mal membrane protein, Pmp22p. By using in vitro systems for 
synthesis and post-translational insertion of Pmp22p we pro-
vide evidence that after synthesis Pmp22p forms two cytosolic 
complexes. Whereas complex I has been identified as associate 
of Pmp22p with the cytosolic chaperonin TRiC, in complex II 
Pmp22p appears tightly bound to a single 40 kDa polypep-
tide, P40. 
TRiC, the GroEL equivalent of the eukaryotic cytoplasm, 
has been demonstrated to exert rather high substrate specific-
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Fig. 5. Crosslinking of Pmp22p of complex II to a 40 kDa polypep-
tide. The pooled fractions 25-27, obtained by gel filtration of the re-
ticulocyte lysate translation mixture, were treated with the hetero-bi-
functional reagent Sulfo-MBS resulting in a crosslinking product of 
60 kDa (1). In the control (2) the reagent was omitted. 
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ity. To date only a small subset of polypeptides, such as actin 
and tubulin, have been shown to require TRiC for folding in 
vivo [14,15]. In a recent study Frydman et al. [16] demon-
strated that a peroxisomal enzyme, firefly luciferase, is also 
folded in vitro by TRiC. The mechanism proposed includes 
the coordinated activity of TRiC with Hsp70/Hsp40. These 
chaperones first bind to the nascent chain, and once the poly-
peptide chain has reached the length of about 250 residues the 
growing chain is transferred to TRiC where folding is com-
pleted [16]. In analogy to this model we favour a similar 
mechanism for the stepwise maturation of Pmp22p. Since 
the molecule consists of 194 amino acid residues, its transfer 
to TRiC may be preceded by other chaperone interactions 
which may include Hsp70/Hsp40 or the ribosome itself. Inter-
action of Pmp22p with TRiC will subsequently mediate the 
formation of complex II which presumably targets Pmp22p to 
a peroxisomal membrane receptor [3,8]. Alternatively, the 
newly synthesized Pmp22p, bypassing TRiC, may directly 
form complex II. In that case the observed interaction of 
Pmp22p with TRiC may reflect a more unspecific binding 
possibly triggered by a limited amount of P 40 in the reticu-
locyte lysate. The observed substrate specificity of TRiC, how-
ever, may argue against this view. 
Insertion competence is predominantly confined to com-
plex II, as shown by the in vitro assay (Fig. 2). Therefore, a 
direct delivery of Pmp22p from TRiC to the peroxisomal 
membrane seems to be rather unlikely, as the release of sub-
strate from TRiC is dependent on the hydrolysis of ATP [17] 
which is not required for the insertion of Pmp22p [3,8]. 
Preliminary attempts to identify P40 by immunological 
means were unsuccessful. Although Pmp22p could be immu-
noprecipitated from the native complex II with a polyclonal 
anti-Pmp22p antiserum, no co-immunoprecipitation was de-
tected using anti-DnaK, anti-DnaJ or anti-Hsp40 antibodies 
indicating that the protein does not belong to these classes of 
chaperones. The work of several laboratories has shown that 
the import of peroxisomal matrix proteins is mediated by 
cytosolic receptors, such as, Pex5p and Pex7p [18-22]. P40 
might function in a way similar to these receptors. 
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